Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Advocates say the shift to CCTA can translate into a broader financial impacts, with some cath labs potentially seeing margin increases of as much as 40%.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
The Los Angeles-based imaging group believes the move will make its DeepHealth subsidiary the “largest provider of radiology clinical AI solutions worldwide.”
Every company is, at once, two things: an economic organization whose survival depends on delivering value in an unforgiving market and a social institution with deep impact on the lives of its employees. The successful CEO must achieve a critical balance between the needs of shareholders and those of employees.
As radiology practices react to the impact of the DRA, some are tapping into the potential of interventional radiology to expand their outpatient services
In June 2008, the Government Accountability Office (GAO) released a long-awaited study on imaging utilization. If CMS follows GAO’s recommendations on effective methods for curbing overutilization, private payors are likely to follow. That’s why the radiology community was disturbed to hear GAO’s statement that overutilization is a far-reaching
In an often-hilarious talk at the Beyond Conference in Washington, DC, on July 24, 2008, political observer and noted handicapper Charlie Cook gave the audience an insider’s view of the 2008 campaign for the presidency, complete with personal anecdotes, acerbic observations, and his own picks for vice-presidential candidates. “If the last year were
The only constant is change is an apt mantra for the imaging industry over the past several years. For the second time in two years, CMS has proposed comprehensive changes in the anti-markup provision of the purchased diagnostic test rule (AMR) in the Medicare Physician Fee Schedule (MPFS) regulations. The most significant of the 2008 finalized
Physicians are understandably suspicious of efficiency efforts in medicine, but nowhere in the Hippocratic oath are they absolved from addressing the appropriate delivery of care
Finally, some good news for imaging. The eleventh-hour override of the president’s veto in early July saved the day for physicians, if only temporarily. Now, the bad news: The cumulative adjustments in the sustainable growth rate affecting the Medicare Physician Fee Schedule will now come due in a mere 18 months. The 10% reduction scheduled for
